Src tyrosine kinase as a drug target in Duchenne muscular dystrophy: a proof-of-concept study in the exercised mdx mouse

Sanarica F.; Boccanegra B.; Mantuano P.; Cappellari O.; De Bellis M.; Conte E.; Camerino G.; Cutrignelli A.; Denora N.; De Luca A.

首页> 外文期刊>Neuromuscular disorders: NMD >Src tyrosine kinase as a drug target in Duchenne muscular dystrophy: a proof-of-concept study in the exercised mdx mouse

【24h】

Src tyrosine kinase as a drug target in Duchenne muscular dystrophy: a proof-of-concept study in the exercised mdx mouse

机译：SRC酪氨酸激酶作为Duchenne肌营养不良的药物靶标：在锻炼MDX鼠标中的概念证明研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Neuromuscular disorders: NMD》 |2019年第1期|共1页
作者
Sanarica F.; Boccanegra B.; Mantuano P.; Cappellari O.; De Bellis M.; Conte E.; Camerino G.; Cutrignelli A.; Denora N.; De Luca A.;
展开▼
作者单位

Univ Bari Bari Italy;

Univ Bari Bari Italy;

Univ Bari Bari Italy;

Univ Manchester Manchester Lancs England;

Univ Bari Bari Italy;

Univ Bari Bari Italy;

Univ Bari Bari Italy;

Univ Bari Bari Italy;

Univ Bari Bari Italy;

Univ Bari Bari Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学;
关键词

相似文献

外文文献
中文文献
专利

1. Src tyrosine kinase as a drug target in Duchenne muscular dystrophy: a proof-of-concept study in the exercised mdx mouse [J] . Sanarica F., Boccanegra B., Mantuano P., Neuromuscular disorders: NMD . 2019,第Suppla1期

机译：SRC酪氨酸激酶作为Duchenne肌营养不良的药物靶标：在锻炼MDX鼠标中的概念证明研究
2. Src tyrosine kinase as potential drug target in Duchenne muscular dystrophy: in vivo and in vitro preclinical studies [J] . Sanarica F., Mantuano P., Cozzoli A., Neuromuscular disorders: NMD . 2017,第Suppla2期

机译：SRC酪氨酸激酶作为Duchenne肌营养不良的潜在药物靶标：体内和体外临床前研究
3. Gene expression in mdx mouse muscle in relation to age and exercise: Aberrant mechanical-metabolic coupling and implications for pre-clinical studies in Duchenne muscular dystrophy [J] . CamerinoG.M., CannoneM., GiustinoA., Human Molecular Genetics . 2014,第21期

机译：与年龄和运动有关的mdx小鼠肌肉中的基因表达：机械代谢代谢异常及其对杜兴氏肌营养不良的临床前研究的意义
4. Development of pharmacodynamic biomarkers for Duchenne muscular dystrophy using exon skipping treatment and mdx mouse model. [C] . Haeri Seol, Meng H Han, Aiping Zhang, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：外显子跳跃治疗和MDX小鼠模型的Duchenne肌营养不良药物动力学生物标志物的发展。
5. Potential Therapies for Bone Health in Glucocorticoid-Treated Mdx Mouse Model of Duchenne Muscular Dystrophy [D] . Yoon, Sung-Hee Seanna. 2019

机译：糖皮质激素处理的MDX小鼠模型骨骼健康的潜在疗法，Duchenne肌营养不良
6. Targeting the Activin Type IIB Receptor to Improve Muscle Mass and Function in the mdx Mouse Model of Duchenne Muscular Dystrophy [O] . Emidio E. Pistilli, Sasha Bogdanovich, Marcus D. Goncalves, 2011

机译：靶向激活素IIB受体以改善Duchenne肌营养不良症的mdx小鼠模型的肌肉质量和功能
7. Exercise Increases Utrophin Protein Expression in the MDX Mouse Model of Duchenne Muscular Dystrophy [O] . Gordon B. S., Lowe D. A., Kostek M. C. 2013

机译：运动增加了Duchenne肌营养不良的MDX小鼠模型中的Utrophin蛋白表达

Src tyrosine kinase as a drug target in Duchenne muscular dystrophy: a proof-of-concept study in the exercised mdx mouse

著录项

相似文献

相关主题

期刊订阅